Clinical Role of Upfront F-18 FDG PET/CT in Determining Biopsy Sites for Lung Cancer Diagnosis.
Byung Geon ParkJae-Kwang LimKyung Min ShinJihoon HongJung Guen ChaSeung Hyun ChoSeo Young ParkHun Kyu RyeomSee Hyung KimAn Na SeoSeung-Ick ChaJaehee LeeHoseok LeeJong Min ParkPublished in: Diagnostics (Basel, Switzerland) (2024)
Upfront PET/CT may have an impact on the selection of the biopsy site for patients with advanced lung cancer, which could result in a lower rate of major complications with no change in the diagnostic yield. Upfront PET/CT demonstrates potential clinical implications for enhancing the safety of lung cancer diagnosis in clinical practice.